A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification

被引:0
|
作者
Shenghao Li
Liyuan Hao
Xiaoyu Hu
Luya Li
机构
[1] Chengdu University of Traditional Chinese Medicine,Department of Pharmacy Department
[2] Hospital of Chengdu University of Traditional Chinese Medicine,undefined
[3] The Fourth Hospital of Hebei Medical University,undefined
关键词
Hepatitis B virus-associated hepatocellular carcinoma; CDK1; CCNB1; Traditional Chinese medicine; Quercetin; Celastrol; Cantharidin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification
    Li, Shenghao
    Hao, Liyuan
    Hu, Xiaoyu
    Li, Luya
    INFECTIOUS AGENTS AND CANCER, 2023, 18 (01)
  • [2] A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology
    Yin, Xiaofeng
    Li, Jinchuan
    Hao, Zheng
    Ding, Rui
    Qiao, Yanan
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [3] Sequencing and Bioinformatics-Based Analyses of the microRNA Transcriptome in Hepatitis B-Related Hepatocellular Carcinoma
    Mizuguchi, Yoshiaki
    Mishima, Takuya
    Yokomuro, Shigeki
    Arima, Yasuo
    Kawahigashi, Yutaka
    Shigehara, Kengo
    Kanda, Tomohiro
    Yoshida, Hiroshi
    Uchida, Eiji
    Tajiri, Takashi
    Takizawa, Toshihiro
    PLOS ONE, 2011, 6 (01):
  • [4] Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma
    Wang, Shanshan
    Cui, Shichang
    Zhao, Wenming
    Qian, Zhiling
    Liu, Hui
    Chen, Yuhan
    Lv, Fudong
    Ding, Hui-Guo
    CANCER BIOMARKERS, 2018, 22 (04) : 631 - 640
  • [5] Exploring the mechanism and experimental verification of puerarin in the treatment of endometrial carcinoma based on network pharmacology and bioinformatics analysis
    Zhiheng Lin
    Xiaohui Sui
    Wenjian Jiao
    Ying Wang
    Junde Zhao
    BMC Complementary Medicine and Therapies, 22
  • [6] Exploring the mechanism and experimental verification of puerarin in the treatment of endometrial carcinoma based on network pharmacology and bioinformatics analysis
    Lin, Zhiheng
    Sui, Xiaohui
    Jiao, Wenjian
    Wang, Ying
    Zhao, Junde
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2022, 22 (01)
  • [7] The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma
    Jiang, Enze
    Shangguan, Anna Junjie
    Chen, Shuangshuang
    Tang, Lin
    Zhao, Shuang
    Yu, Zhenghong
    CANCER LETTERS, 2016, 379 (02) : 262 - 267
  • [8] The ALPPS in the Treatment of Hepatitis B-Related Hepatocellular Carcinoma With Cirrhosis: A Single-Center Study and Literature Review
    Cai, Xiujun
    Tong, Yifan
    Yu, Hong
    Liang, Xiao
    Wang, Yifan
    Liang, Yuelong
    Li, Zheyong
    Peng, Shuyong
    Lau, W. Y.
    SURGICAL INNOVATION, 2017, 24 (04) : 358 - 364
  • [9] Epidemiology, Treatment Patterns and Survival in Canadian Patients With Chronic Hepatitis B-Related Hepatocellular Carcinoma
    Sachar, Y.
    Congly, S. E.
    Burak, K. W.
    Manko, A.
    Ko, H. H.
    Ramji, A.
    Rahman, H. S.
    Talia, J.
    Jeyaparan, J.
    Wong, D. W.
    Fung, S.
    Cooper, C.
    Kelly, E. M.
    Ma, M. M.
    Bailey, R.
    Minuk, G.
    Wong, A.
    Doucette, K.
    Elkashab, M.
    Sebastiani, G.
    Wong, P.
    Coffin, C. S.
    Brahmania, M.
    JOURNAL OF VIRAL HEPATITIS, 2024, 31 (11) : 739 - 745
  • [10] Study on the mechanism of action of Scutellaria barbata on hepatocellular carcinoma based on network pharmacology and bioinformatics
    Yang, An-Yin
    Liu, Hong-Li
    Yang, Yong-Feng
    FRONTIERS IN PHARMACOLOGY, 2023, 13